儿童及青少年透析起始时eGFR与死亡率的关系
该回顾性队列研究纳入美国肾脏数据系统1995-2016年9963例1-17岁透析患者,评估透析起始时eGFR与全因死亡的关系。中位随访1.4年,发现较高eGFR与较高死亡风险相关,eGFR≥12相比7-<9的校正HR为1.31。
要点
- 透析起始eGFR较高与儿童透析患者死亡风险增加相关。
- eGFR<5相比7-<9的校正HR为0.57,死亡风险更低。
- 6岁及以上患者中关系一致,<6岁患者关联减弱。
核心结论
- 透析起始时较高eGFR与儿童及青少年透析患者较高的死亡风险相关。
研究设计与样本
- 回顾性队列研究,纳入美国肾脏数据系统1995-2016年9963例1-17岁初始透析患者。
主要发现
- 中位eGFR为7.8(IQR 5.6-10.5)mL/min/1.73m2,中位年龄13(IQR 9-16)岁。
- 中位随访1.4(IQR 0.7-2.7)年,观察到696例死亡,粗死亡率为31/1000患者年。
- 相比eGFR 7-<9 mL/min/1.73m2,eGFR<5的校正HR为0.57(95% CI 0.43-0.74),eGFR≥12的校正HR为1.31(95% CI 1.05-1.65)。
- 年龄分层分析中,6岁及以上患者关系一致,6岁以下患者关联减弱(P交互=0.002)。
临床怎么用
- 儿童透析起始时eGFR较高可能提示死亡风险增加,需个体化评估透析时机。
局限性
- 血清肌酐测量方法可能导致eGFR误差。
- 存在与透析起始eGFR相关的未测量混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: The association of estimated glomerular filtration rate (eGFR) at dialysis therapy initiation with mortality among adult dialysis patients has been greatly debated, with some studies showing no benefit from early dialysis therapy initiation. However, this association has not been well investigated in pediatric dialysis patients. The objective of this study was to evaluate the mortality risk associated with eGFR at dialysis therapy initiation in children and adolescents with kidney failure. STUDY DESIGN: Retrospective cohort study. SETTING & PARTICIPANTS: 9,963 incident dialysis patients aged 1 to 17 years in the US Renal Data System registry (1995-2016). PREDICTOR: eGFRs at dialysis therapy initiation calculated using the pediatric-specific bedside Schwartz equation (<5, 5-<7, 7-<9, 9-<12, and ≥12mL/min/1.73m2). OUTCOME: Time to all-cause death. ANALYTICAL APPROACH: Cox proportional hazards regression adjusted for case-mix variables, height, body mass index, hemoglobin level, and serum albumin level. RESULTS: Median eGFR was 7.8 (IQR, 5.6-10.5) mL/min/1.73m2 and median age was 13 (IQR, 9-16) years. 696 deaths were observed during the median follow-up of 1.4 (IQR, 0.7-2.7) years, and overall crude mortality rate was 31 per 1,000 patient-years. There appeared to be a trend toward higher mortality risk across higher eGFRs at dialysis therapy initiation. Compared with eGFRs of 7 to <9mL/min/1.73m2, eGFRs <5 and ≥12mL/min/1.73m2 were associated with lower and higher mortality, with adjusted HRs of 0.57 (95% CI, 0.43-0.74) and 1.31 (95% CI, 1.05-1.65), respectively. In age-stratified analysis, there were consistent relationships among patients 6 years and older while the eGFR-mortality association was attenuated among patients younger than 6 years (Pinteraction = 0.002). LIMITATIONS: Possible errors in eGFRs due to methods for serum creatinine measurement. Unmeasured confounders related to eGFR at dialysis therapy initiation. CONCLUSIONS: Higher eGFR at dialysis therapy initiation was associated with higher mortality risk. Further studies of eGFR at initiation are needed in pediatric dialysis patients, especially among those younger than 6 years.
引用
- Okuda Y, Soohoo M, Tang Y, et al. Estimated GFR at Dialysis Initiation and Mortality in Children and Adolescents. Am J Kidney Dis. 2019. PMID: 30833086. doi:10.1053/j.ajkd.2018.12.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。